232 related articles for article (PubMed ID: 10203695)
1. Crm-A, bcl-2 and NDGA inhibit CD95L-induced apoptosis of malignant glioma cells at the level of caspase 8 processing.
Wagenknecht B; Schulz JB; Gulbins E; Weller M
Cell Death Differ; 1998 Oct; 5(10):894-900. PubMed ID: 10203695
[TBL] [Abstract][Full Text] [Related]
2. Sensitization to CD95 ligand-induced apoptosis in human glioma cells by hyperthermia involves enhanced cytochrome c release.
Hermisson M; Wagenknecht B; Wolburg H; Glaser T; Dichgans J; Weller M
Oncogene; 2000 May; 19(19):2338-45. PubMed ID: 10822385
[TBL] [Abstract][Full Text] [Related]
3. Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells.
Glaser T; Wagenknecht B; Weller M
Oncogene; 2001 Aug; 20(35):4757-67. PubMed ID: 11521188
[TBL] [Abstract][Full Text] [Related]
4. C2-ceramide signaling in glioma cells: synergistic enhancement of CD95-mediated, caspase-dependent apoptosis.
Wagenknecht B; Roth W; Gulbins E; Wolburg H; Weller M
Cell Death Differ; 2001 Jun; 8(6):595-602. PubMed ID: 11536010
[TBL] [Abstract][Full Text] [Related]
5. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
6. Death ligand/receptor-independent caspase activation mediates drug-induced cytotoxic cell death in human malignant glioma cells.
Glaser T; Wagenknecht B; Groscurth P; Krammer PH; Weller M
Oncogene; 1999 Sep; 18(36):5044-53. PubMed ID: 10490841
[TBL] [Abstract][Full Text] [Related]
7. Ceramide-induced apoptosis in fas-resistant Hodgkin's disease cell lines is caspase independent.
Metkar SS; Anand M; Manna PP; Naresh KN; Nadkarni JJ
Exp Cell Res; 2000 Feb; 255(1):18-29. PubMed ID: 10666330
[TBL] [Abstract][Full Text] [Related]
8. Ordering of ceramide formation, caspase activation, and Bax/Bcl-2 expression during etoposide-induced apoptosis in C6 glioma cells.
Sawada M; Nakashima S; Banno Y; Yamakawa H; Hayashi K; Takenaka K; Nishimura Y; Sakai N; Nozawa Y
Cell Death Differ; 2000 Sep; 7(9):761-72. PubMed ID: 11042671
[TBL] [Abstract][Full Text] [Related]
9. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release.
Röhn TA; Wagenknecht B; Roth W; Naumann U; Gulbins E; Krammer PH; Walczak H; Weller M
Oncogene; 2001 Jul; 20(31):4128-37. PubMed ID: 11464279
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
Hermisson M; Weller M
Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082
[TBL] [Abstract][Full Text] [Related]
11. Caspase-dependent chemotherapy-induced death of glioma cells requires mitochondrial cytochrome c release.
Glaser T; Weller M
Biochem Biophys Res Commun; 2001 Feb; 281(2):322-7. PubMed ID: 11181049
[TBL] [Abstract][Full Text] [Related]
12. Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma.
Wagenknecht B; Glaser T; Naumann U; Kügler S; Isenmann S; Bähr M; Korneluk R; Liston P; Weller M
Cell Death Differ; 1999 Apr; 6(4):370-6. PubMed ID: 10381630
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of CD95L-induced apoptosis of human malignant glioma cells by topotecan involves inhibition of RNA synthesis but not changes in CD95 or CD95L protein expression.
Winter S; Weller M
J Pharmacol Exp Ther; 1998 Sep; 286(3):1374-82. PubMed ID: 9732400
[TBL] [Abstract][Full Text] [Related]
14. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2.
Dirsch VM; Stuppner H; Vollmar AM
Cancer Res; 2001 Aug; 61(15):5817-23. PubMed ID: 11479221
[TBL] [Abstract][Full Text] [Related]
15. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
An S; Yap D; Knox KA
Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
[TBL] [Abstract][Full Text] [Related]
16. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand.
Zipp F; Martin R; Lichtenfels R; Roth W; Dichgans J; Krammer PH; Weller M
J Immunol; 1997 Sep; 159(5):2108-15. PubMed ID: 9278296
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53.
Mathiasen IS; Lademann U; Jäättelä M
Cancer Res; 1999 Oct; 59(19):4848-56. PubMed ID: 10519395
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Fas-induced apoptosis by Bcl-2.
Kawahara A; Kobayashi T; Nagata S
Oncogene; 1998 Nov; 17(20):2549-54. PubMed ID: 9840917
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent.
Ochs K; Kaina B
Cancer Res; 2000 Oct; 60(20):5815-24. PubMed ID: 11059778
[TBL] [Abstract][Full Text] [Related]
20. Acid sphingomyelinase activation requires caspase-8 but not p53 nor reactive oxygen species during Fas-induced apoptosis in human glioma cells.
Sawada M; Nakashima S; Kiyono T; Yamada J; Hara S; Nakagawa M; Shinoda J; Sakai N
Exp Cell Res; 2002 Feb; 273(2):157-68. PubMed ID: 11822871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
